More News
27 August 2013
Sangamo BioSciences to Acquire Ceregene26 August 2013
New Therapies to Spur Growth of the Acute Myeloid Leukemia Market, but Breakthrough Drug Still Awaited26 August 2013
Chiesi Group to Acquire Zymenex26 August 2013
MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune23 August 2013
Shire and Santaris extend their strategic alliance to discover and develop LNA-drugs in the rare genetic disease field22 August 2013
International partnership receives funding to develop a drug product to fight schistosomiasis (bilharzia) in children21 August 2013
Evotec and the Jain Foundation Announce Extension of Research Collaboration in Skeletal Muscular Dystrophy Diseases15 August 2013
Amunix Announces Update to Licensing Agreement with Janssen for Its Proprietary XTEN Technology15 August 2013
Dendright enters into collaboration with Janssen Biotech, Inc. to develop rheumatoid arthritis immunotherapy14 August 2013
Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-EnabledTM Topiramate Injection13 August 2013
Sanford-Burnham Collaborates With Pfizer to Identify Targets for Treatment of Insulin Resistance and Diabetes13 August 2013
Sunovion Pharmaceuticals Inc. and Afraxis, Inc. Announce Novel Drug Discovery Partnership1 August 2013
Nascent AD Biomarker Market Provides Opportunities for Companies with Innovative Products to Establish their PresenceNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports